All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

ACR and other medical societies recently wrote to the secretaries of State and Homeland Security to voice their concern about ongoing staffing issues.